Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Nov 23;103(11):1742-8.
doi: 10.1038/sj.bjc.6605949. Epub 2010 Oct 26.

A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status

Affiliations

A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status

W J Louwman et al. Br J Cancer. .

Abstract

Background: Comorbidity and socioeconomic status (SES) may be related among cancer patients.

Method: Population-based cancer registry study among 72,153 patients diagnosed during 1997-2006.

Results: Low SES patients had 50% higher risk of serious comorbidity than those with high SES. Prevalence was increased for each cancer site. Low SES cancer patients had significantly higher risk of also having cardiovascular disease, chronic obstructive pulmonary diseases, diabetes mellitus, cerebrovascular disease, tuberculosis, dementia, and gastrointestinal disease. One-year survival was significantly worse in lowest vs highest SES, partly explained by comorbidity.

Conclusion: This illustrates the enormous heterogeneity of cancer patients and stresses the need for optimal treatment of cancer patients with a variety of concomitant chronic conditions.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Number of concomitant diseases among cancer patients diagnosed in 1997–2006 in the Southeastern Netherlands. *Distribution of number of concomitant diseases significantly different from the highest socioeconomic status category.
Figure 2
Figure 2
Risk of four concomitant diseases among cancer patients with the lowest socioeconomic status (SES) compared with those with the highest SES (=reference, 1.00) according to tumour localisation with adjustment for age and gender. *95% confidence interval does not include 1.00; # No reliable estimate because <5 cases in reference category.

References

    1. Ayanian JZ, Zaslavsky AM, Fuchs CS, Guadagnoli E, Creech CM, Cress RD, O’Connor LC, West DW, Allen ME, Wolf RE, Wright WE (2003) Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol 21: 1293–1300 - PubMed
    1. Berkman LF, Macintyre S (1997) The measurement of social class in health studies: old measures and new formulations. IARC Sci Publ 138: 51–64 - PubMed
    1. Bos V, Kunst AE, Mackenbach JP (2000) Nationale gegevens over sociaal-economische sterfteverschillen op basis van informatie over kleine geografische eenheden. Verslag aan de programmacommissie Sociaal-economische gezondheidsverschillen II. Instituut Maatschappelijke Gezondheidszorg, Erasmus Universiteit: Rotterdam
    1. Bos V, Kunst AE, Mackenbach JP (2001) De omvang van sociaal-economische sterfteverschillen gemeten op buurtniveau: vergelijking met schattingen op basis van informatie op individueel niveau. In Sociaal-economische gezonheidsverschillen: Van verklaren naar verkleinen, Stronks K (ed) Vol. 5, pp 8–20. Zon/MW: Den Haag
    1. Bueno-de-Mesquita HB, Ferrari P, Riboli E (2002) Plant foods and the risk of colorectal cancer in Europe: preliminary findings. IARC Sci Publ 156: 89–95 - PubMed

Publication types